Literature DB >> 16299330

Leishmania pifanoi amastigotes avoid macrophage production of superoxide by inducing heme degradation.

Nam-Kha Pham1, Jennifer Mouriz, Peter E Kima.   

Abstract

Whereas infections of macrophages by promastigote forms of Leishmania mexicana pifanoi induce the production of superoxide, infections by amastigotes barely induce superoxide production. Several approaches were employed to gain insight into the mechanism by which amastigotes avoid eliciting superoxide production. First, in experiments with nitroblue tetrazolium, we found that 25% of parasitophorous vacuoles (PVs) that harbor promastigotes are positive for the NADPH oxidase complex, in contrast to only 2% of PVs that harbor amastigotes. Second, confocal microscope analyses of infected cells labeled with antibodies to gp91phox revealed that this enzyme subunit is found in PVs that harbor amastigotes. Third, in immunoblots of subcellular fractions enriched with PVs from amastigote-infected cells and probed with antibodies to gp91phox, only the 65-kDa premature form of gp91phox was found. In contrast, subcellular fractions from macrophages that ingested zymosan particles contained both the 91- and 65-kDa forms of gp91phox. This suggested that only the immature form of gp91phox is recruited to PVs that harbor amastigotes. Given that gp91phox maturation is dependent on the availability of heme, we found that infections by Leishmania parasites induce an increase in heme oxygenase 1 (HO-1), the rate-limiting enzyme in heme degradation. Infections by amastigotes performed in the presence of metalloporphyrins, which are inhibitors of HO-1, resulted in superoxide production by infected macrophages. Taken together, we propose that Leishmania amastigotes avoid superoxide production by inducing an increase in heme degradation, which results in blockage of the maturation of gp91phox, which prevents assembly of the NADPH oxidase enzyme complex.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16299330      PMCID: PMC1307057          DOI: 10.1128/IAI.73.12.8322-8333.2005

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  44 in total

1.  Processing and maturation of flavocytochrome b558 include incorporation of heme as a prerequisite for heterodimer assembly.

Authors:  F R DeLeo; J B Burritt; L Yu; A J Jesaitis; M C Dinauer; W M Nauseef
Journal:  J Biol Chem       Date:  2000-05-05       Impact factor: 5.157

2.  Interleukin-10 and interleukin-4 inhibit intracellular killing of Leishmania infantum and Leishmania major by human macrophages by decreasing nitric oxide generation.

Authors:  I Vouldoukis; P A Bécherel; V Riveros-Moreno; M Arock; O da Silva; P Debré; D Mazier; M D Mossalayi
Journal:  Eur J Immunol       Date:  1997-04       Impact factor: 5.532

Review 3.  An evidence-based review of important issues concerning neonatal hyperbilirubinemia.

Authors:  Stanley Ip; Mei Chung; John Kulig; Rebecca O'Brien; Robert Sege; Stephan Glicken; M Jeffrey Maisels; Joseph Lau
Journal:  Pediatrics       Date:  2004-07       Impact factor: 7.124

4.  Anaplasma phagocytophilum modulates gp91phox gene expression through altered interferon regulatory factor 1 and PU.1 levels and binding of CCAAT displacement protein.

Authors:  Venetta Thomas; Swapna Samanta; Caiyun Wu; Nancy Berliner; Erol Fikrig
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

5.  Heme metabolism in promastigotes of Leishmania donovani.

Authors:  P Srivastava; G D Sharma; K K Kamboj; A K Rastogi; V C Pandey
Journal:  Mol Cell Biochem       Date:  1997-06       Impact factor: 3.396

6.  Heme oxygenase-1 expression inhibits dendritic cell maturation and proinflammatory function but conserves IL-10 expression.

Authors:  Christine Chauveau; Séverine Rémy; Pierre Joseph Royer; Marcelo Hill; Séverine Tanguy-Royer; François-Xavier Hubert; Laurent Tesson; Régis Brion; Gaëlle Beriou; Marc Gregoire; Régis Josien; Maria Cristina Cuturi; Ignacio Anegon
Journal:  Blood       Date:  2005-05-26       Impact factor: 22.113

7.  Inhibition of human neutrophil NADPH oxidase by Chlamydia serovars E, K, and L2.

Authors:  A I Tauber; N Pavlotsky; J S Lin; P A Rice
Journal:  Infect Immun       Date:  1989-04       Impact factor: 3.441

8.  Impairment of the human phagocyte oxidative responses caused by Leishmania lipophosphoglycan (LPG): in vitro studies.

Authors:  O Brandonisio; M A Panaro; R Marzio; A Marangi; S M Faliero; E Jirillo
Journal:  FEMS Immunol Med Microbiol       Date:  1994-01

9.  Infection of human and murine macrophages with Leishmania major is associated with early parasite heat shock protein synthesis but fails to induce a host cell stress response.

Authors:  S Kantengwa; I Müller; J Louis; B S Polla
Journal:  Immunol Cell Biol       Date:  1995-02       Impact factor: 5.126

10.  Macrophage microbicidal mechanisms in vivo: reactive nitrogen versus oxygen intermediates in the killing of intracellular visceral Leishmania donovani.

Authors:  H W Murray; C F Nathan
Journal:  J Exp Med       Date:  1999-02-15       Impact factor: 14.307

View more
  34 in total

1.  Toll-like receptors participate in macrophage activation and intracellular control of Leishmania (Viannia) panamensis.

Authors:  Carolina Gallego; Douglas Golenbock; Maria Adelaida Gomez; Nancy Gore Saravia
Journal:  Infect Immun       Date:  2011-04-25       Impact factor: 3.441

Review 2.  Are reactive oxygen species always detrimental to pathogens?

Authors:  Claudia N Paiva; Marcelo T Bozza
Journal:  Antioxid Redox Signal       Date:  2013-10-26       Impact factor: 8.401

3.  Human classical monocytes control the intracellular stage of Leishmania braziliensis by reactive oxygen species.

Authors:  Fernanda O Novais; Ba T Nguyen; Daniel P Beiting; Lucas P Carvalho; Nelson D Glennie; Sara Passos; Edgar M Carvalho; Phillip Scott
Journal:  J Infect Dis       Date:  2014-01-07       Impact factor: 5.226

Review 4.  Iron and Heme Metabolism at the Leishmania-Host Interface.

Authors:  Maria Fernanda Laranjeira-Silva; Iqbal Hamza; José M Pérez-Victoria
Journal:  Trends Parasitol       Date:  2020-01-28

Review 5.  Role of NADPH oxidase in formation and function of multinucleated giant cells.

Authors:  Mark T Quinn; Igor A Schepetkin
Journal:  J Innate Immun       Date:  2009-07-07       Impact factor: 7.349

6.  Heme oxygenase-1 promotes the persistence of Leishmania chagasi infection.

Authors:  Nívea F Luz; Bruno B Andrade; Daniel F Feijó; Théo Araújo-Santos; Graziele Q Carvalho; Daniela Andrade; Daniel R Abánades; Enaldo V Melo; Angela M Silva; Cláudia I Brodskyn; Manoel Barral-Netto; Aldina Barral; Rodrigo P Soares; Roque P Almeida; Marcelo T Bozza; Valéria M Borges
Journal:  J Immunol       Date:  2012-03-28       Impact factor: 5.422

7.  Leishmania parasitophorous vacuoles interact continuously with the host cell's endoplasmic reticulum; parasitophorous vacuoles are hybrid compartments.

Authors:  Blaise Ndjamen; Byung-Ho Kang; Kiyotaka Hatsuzawa; Peter E Kima
Journal:  Cell Microbiol       Date:  2010-10       Impact factor: 3.715

8.  Inhibition of dendritic cell apoptosis by Leishmania mexicana amastigotes.

Authors:  Laila Gutiérrez-Kobeh; Eleané de Oyarzabal; Jesús Argueta; Arturo Wilkins; Norma Salaiza; Edith Fernández; Oliver López; Magdalena Aguirre; Ingeborg Becker
Journal:  Parasitol Res       Date:  2013-02-19       Impact factor: 2.289

9.  Identification of Leishmania proteins preferentially released in infected cells using change mediated antigen technology (CMAT).

Authors:  Peter E Kima; J Alfredo Bonilla; Eumin Cho; Blaise Ndjamen; Johnathan Canton; Nicole Leal; Martin Handfield
Journal:  PLoS Negl Trop Dis       Date:  2010-10-05

10.  Heme oxygenase-1 dysregulates macrophage polarization and the immune response to Helicobacter pylori.

Authors:  Alain P Gobert; Thomas Verriere; Mohammad Asim; Daniel P Barry; M Blanca Piazuelo; Thibaut de Sablet; Alberto G Delgado; Luis E Bravo; Pelayo Correa; Richard M Peek; Rupesh Chaturvedi; Keith T Wilson
Journal:  J Immunol       Date:  2014-08-08       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.